Related Experiment Video
Updated: Nov 7, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection
Seyed Mohammad Ali Hashemi1,2, Marijn Thijssen3, Seyed Younes Hosseini1
1Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract:
The SARS-CoV-2 pandemic has become one of the most serious health concerns globally. Although multiple vaccines have recently been approved for the prevention of coronavirus disease 2019 (COVID-19), an effective treatment is still lacking. Our knowledge of the pathogenicity of this virus is still incomplete. Studies have revealed that viral factors such as the viral load, duration of exposure to the virus, and viral mutations are important variables in COVID-19 outcome. Furthermore, host factors, including age, health condition, co-morbidities, and genetic background, might also be involved in clinical manifestations and infection outcome. This review focuses on the importance of variations in the host genetic background and pathogenesis of SARS-CoV-2. We will discuss the significance of polymorphisms in the ACE-2, TMPRSS2, vitamin D receptor, vitamin D binding protein, CD147, glucose-regulated protein 78 kDa, dipeptidyl peptidase-4 (DPP4), neuropilin-1, heme oxygenase, apolipoprotein L1, vitamin K epoxide reductase complex 1 (VKORC1), and immune system genes for the clinical outcome of COVID-19.
Insights
Host genetic variations significantly influence COVID-19 severity. Understanding these genetic factors, like ACE-2 and immune system genes, is crucial for developing effective treatments for coronavirus disease 2019 (COVID-19).
Area of Science:
- Genetics
- Virology
- Immunology
Background:
- The global SARS-CoV-2 pandemic highlights the urgent need for effective COVID-19 treatments.
- While vaccines exist, understanding COVID-19 pathogenesis remains incomplete.
- Both viral and host factors influence COVID-19 outcomes.
Purpose of the Study:
- To review the role of host genetic variations in SARS-CoV-2 pathogenesis.
- To highlight specific gene polymorphisms associated with COVID-19 clinical outcomes.
Main Methods:
- Literature review focusing on genetic polymorphisms and COVID-19.
- Analysis of studies investigating host factors in SARS-CoV-2 infection.
Main Results:
- Host genetic background, including variations in ACE-2, TMPRSS2, and immune genes, impacts COVID-19 severity.
- Polymorphisms in genes like vitamin D receptor and DPP4 may influence disease progression.
- Genetic factors contribute to individual differences in COVID-19 manifestations.
Conclusions:
- Host genetics are a critical determinant of COVID-19 outcomes.
- Targeting host genetic factors could lead to novel therapeutic strategies for COVID-19.
- Further research into host-pathogen genetic interactions is warranted.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genetic Variation
Genes exist in different versions called alleles,...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Multiple Allele Traits

